During the past 12 months, Shinpoong Pharmaceutical Co's average Total Assets Growth Rate was -6.40% per year.
During the past 3 years, the average Total Assets Growth Rate was -1.40% per year.
During the past 5 years, the average Total Assets Growth Rate was -1.80% per year.
During the past 10 years, the average Total Assets Growth Rate was -3.50% per year.
During the past 13 years, Shinpoong Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 14.10%. The lowest was -7.00%. And the median was -1.15%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shinpoong Pharmaceutical Co Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shinpoong Pharmaceutical Co (XKRX:019170) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Shinpoong Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Shinpoong Pharmaceutical Co Total Assets Related Terms
Thank you for viewing the detailed overview of Shinpoong Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Shinpoong Pharmaceutical Co (XKRX:019170) Business Description
Shinpoong Pharmaceutical Co Ltd specializes in manufacturing remedy drugs and also active pharmaceutical ingredients and finished products. Its products include Newsicam, Caravenal, Roxagen, Clamoxin duo, Ceroxim, and Clocin. The firm's production facilities are located at Gyeonggi-do and Cheongwon-gun.
Shinpoong Pharmaceutical Co (XKRX:019170) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:019170 has been successfully added to your 